CY1108099T1 - Ενωσεις αμμωνιου κυκλοδεξτρινης μετατραπεισες σε τετρατοταγη δομη - Google Patents
Ενωσεις αμμωνιου κυκλοδεξτρινης μετατραπεισες σε τετρατοταγη δομηInfo
- Publication number
- CY1108099T1 CY1108099T1 CY20081100523T CY081100523T CY1108099T1 CY 1108099 T1 CY1108099 T1 CY 1108099T1 CY 20081100523 T CY20081100523 T CY 20081100523T CY 081100523 T CY081100523 T CY 081100523T CY 1108099 T1 CY1108099 T1 CY 1108099T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compound
- cyclodextrine
- ammonium
- square surface
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 230000002924 anti-infective effect Effects 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000002993 cycloalkylene group Chemical group 0.000 abstract 1
- -1 cyclodextrin compound Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02013074 | 2002-06-13 | ||
| EP02028554 | 2002-12-20 | ||
| EP03740232A EP1515729B1 (en) | 2002-06-13 | 2003-06-12 | Quaternised ammonium cyclodextrin compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1108099T1 true CY1108099T1 (el) | 2014-02-12 |
Family
ID=29737927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081100523T CY1108099T1 (el) | 2002-06-13 | 2008-05-20 | Ενωσεις αμμωνιου κυκλοδεξτρινης μετατραπεισες σε τετρατοταγη δομη |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20050222085A1 (enExample) |
| EP (1) | EP1515729B1 (enExample) |
| JP (2) | JP4773721B2 (enExample) |
| CN (1) | CN100589809C (enExample) |
| AT (1) | ATE386532T1 (enExample) |
| AU (1) | AU2003276957A1 (enExample) |
| BR (1) | BR0311722A (enExample) |
| CA (1) | CA2487332C (enExample) |
| CY (1) | CY1108099T1 (enExample) |
| DE (1) | DE60319221T2 (enExample) |
| DK (1) | DK1515729T3 (enExample) |
| ES (1) | ES2301807T3 (enExample) |
| PT (1) | PT1515729E (enExample) |
| SI (1) | SI1515729T1 (enExample) |
| WO (1) | WO2003105867A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100678824B1 (ko) * | 2005-02-04 | 2007-02-05 | 한미약품 주식회사 | 용해성이 증가된 무정형 타크로리무스 고체분산체 및 이를포함하는 약제학적 조성물 |
| EP2522343A1 (en) | 2006-03-28 | 2012-11-14 | Javelin Pharmaceuticals, Inc. | Formulations of Low Dose Diclofenac and Beta-Cyclodextrin |
| WO2008120249A1 (en) * | 2007-03-30 | 2008-10-09 | Sifi S.P.A. | Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use |
| CN101757621B (zh) * | 2008-11-28 | 2012-07-04 | 天津金耀集团有限公司 | 一种眼部抗炎的环糊精包合药物组合物 |
| US9642920B2 (en) * | 2009-06-03 | 2017-05-09 | Case Western Reserve University | Therapeutic agent delivery system and method |
| CN102276761A (zh) * | 2010-06-11 | 2011-12-14 | 南京理工大学 | 单取代铵基正电型-β-环糊精及其制备方法 |
| GB201114459D0 (en) * | 2011-08-22 | 2011-10-05 | Isis Innovation | Anti-bacterial compounds |
| CN103497275B (zh) * | 2013-08-09 | 2015-12-23 | 华北电力大学（保定） | 一种抗菌、抗病毒胍盐星形聚合物及其制备方法和应用 |
| CZ307458B6 (cs) * | 2014-11-25 | 2018-09-12 | Spur A.S. | Vícevrstvý kryt rány s aktivní vrstvou a způsob jeho výroby |
| EP3227379B1 (en) * | 2014-12-02 | 2020-07-29 | B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University | Quaternized starches for use as anti-microbial agents |
| CN109487588B (zh) * | 2018-11-19 | 2021-04-20 | 绍兴永通印花有限公司 | 一种印花用涤纶织物处理液及其使用方法 |
| CN113056516B (zh) | 2019-02-14 | 2022-05-13 | 赛克洛珀股份有限公司 | 带有电荷的环糊精聚合物材料以及其制造和使用方法 |
| CN109836512A (zh) * | 2019-03-04 | 2019-06-04 | 西南石油大学 | 一种新型β-CD双子表面活性剂为稠化剂的清洁压裂液 |
| CN112386710A (zh) * | 2020-12-09 | 2021-02-23 | 星拜(苏州)生物科技有限公司 | 一种利用包埋技术改善紫檀芪水溶性的方法 |
| CN116987213B (zh) * | 2022-04-26 | 2025-09-09 | 中国石油化工股份有限公司 | 一种具有表面活性剂功能的化合物、一种表面活性剂及其制备方法 |
| KR20250161522A (ko) | 2023-01-12 | 2025-11-17 | 사이클로퓨어, 인코포레이티드 | 중합체 시클로덱스트린 흡착제의 재생 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3453257A (en) * | 1967-02-13 | 1969-07-01 | Corn Products Co | Cyclodextrin with cationic properties |
| JPS58210901A (ja) * | 1982-06-01 | 1983-12-08 | Kao Corp | シクロデキストリン誘導体およびその製造方法 |
| IT1229133B (it) * | 1989-03-09 | 1991-07-22 | Farmhispania | Sali ammonici di policiclodestrine per l'impiego come agenti ipocolesterolemizzanti |
| KR927003645A (ko) * | 1990-05-21 | 1992-12-18 | 후지다 히로미찌 | 씨클로덱스트린 유도체 |
| JPH0481401A (ja) * | 1990-07-24 | 1992-03-16 | Toppan Printing Co Ltd | シクロデキストリン誘導体 |
| JPH0665307A (ja) * | 1992-06-17 | 1994-03-08 | Sankyo Co Ltd | シクロデキストリン誘導体 |
| AU3609795A (en) * | 1994-10-10 | 1996-05-02 | Novartis Ag | Ophthalmic and aural compositions containing diclofenac potassium |
| JP3297969B2 (ja) * | 1994-12-26 | 2002-07-02 | ライオン株式会社 | 点眼剤 |
| US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| TW434023B (en) * | 1995-09-18 | 2001-05-16 | Novartis Ag | Preserved ophthalmic composition |
| WO1999042111A1 (en) * | 1998-02-23 | 1999-08-26 | Cyclops, Ehf. | High-energy cyclodextrin complexes |
-
2003
- 2003-06-12 AU AU2003276957A patent/AU2003276957A1/en not_active Abandoned
- 2003-06-12 ES ES03740232T patent/ES2301807T3/es not_active Expired - Lifetime
- 2003-06-12 CN CN03813614A patent/CN100589809C/zh not_active Expired - Fee Related
- 2003-06-12 DE DE60319221T patent/DE60319221T2/de not_active Expired - Lifetime
- 2003-06-12 PT PT03740232T patent/PT1515729E/pt unknown
- 2003-06-12 DK DK03740232T patent/DK1515729T3/da active
- 2003-06-12 AT AT03740232T patent/ATE386532T1/de active
- 2003-06-12 SI SI200331202T patent/SI1515729T1/sl unknown
- 2003-06-12 EP EP03740232A patent/EP1515729B1/en not_active Expired - Lifetime
- 2003-06-12 US US10/516,247 patent/US20050222085A1/en not_active Abandoned
- 2003-06-12 JP JP2004512769A patent/JP4773721B2/ja not_active Expired - Fee Related
- 2003-06-12 CA CA2487332A patent/CA2487332C/en not_active Expired - Fee Related
- 2003-06-12 BR BR0311722-7A patent/BR0311722A/pt not_active IP Right Cessation
- 2003-06-12 WO PCT/EP2003/006192 patent/WO2003105867A1/en not_active Ceased
-
2008
- 2008-05-20 CY CY20081100523T patent/CY1108099T1/el unknown
- 2008-09-26 US US12/238,473 patent/US20090110734A1/en not_active Abandoned
-
2010
- 2010-08-20 JP JP2010185238A patent/JP2011006448A/ja active Pending
-
2011
- 2011-09-16 US US13/234,912 patent/US20120004158A1/en not_active Abandoned
-
2012
- 2012-12-21 US US13/723,257 patent/US20130137657A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2487332C (en) | 2012-05-15 |
| WO2003105867A1 (en) | 2003-12-24 |
| JP4773721B2 (ja) | 2011-09-14 |
| US20130137657A1 (en) | 2013-05-30 |
| AU2003276957A1 (en) | 2003-12-31 |
| JP2011006448A (ja) | 2011-01-13 |
| PT1515729E (pt) | 2008-05-30 |
| ATE386532T1 (de) | 2008-03-15 |
| EP1515729B1 (en) | 2008-02-20 |
| CA2487332A1 (en) | 2003-12-24 |
| EP1515729A1 (en) | 2005-03-23 |
| US20120004158A1 (en) | 2012-01-05 |
| CN100589809C (zh) | 2010-02-17 |
| BR0311722A (pt) | 2005-03-01 |
| CN1658888A (zh) | 2005-08-24 |
| DK1515729T3 (da) | 2008-06-16 |
| ES2301807T3 (es) | 2008-07-01 |
| US20090110734A1 (en) | 2009-04-30 |
| US20050222085A1 (en) | 2005-10-06 |
| DE60319221D1 (de) | 2008-04-03 |
| DE60319221T2 (de) | 2009-03-05 |
| SI1515729T1 (sl) | 2008-08-31 |
| JP2005529175A (ja) | 2005-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118988T1 (el) | Τροποποιημενα σακχαριδια | |
| DE60319221D1 (de) | Quaternisierte ammoniumcyclodextrinverbindungen | |
| CY1122065T1 (el) | Ενωσεις αλκυλ-αμιδο-υποκατεστημενου πυριδυλιου χρησιμες ως διαμορφωτες των αποκρισεων il-12, il-23 και/η ιfναλφα | |
| CY1107830T1 (el) | Αντικαρκινικα αναλογα | |
| CY1108313T1 (el) | Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6 | |
| CY1113438T1 (el) | Οξεο-καλυμμενο τεταρτοταγοποιημενο πολυμερες και συνθεσεις που περιλαμβανουν τετοιο πολυμερες | |
| RU2225404C2 (ru) | ПРОИЗВОДНЫЕ ПИПЕРАЗИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ ФАКТОРА Хa | |
| PT1296713E (pt) | Oligodesoxinucleotidos imunoestimuladores | |
| EA200970311A1 (ru) | ПРОИЗВОДНЫЕ 2-АРИЛ-6-ФЕНИЛИМИДАЗО[1,2-α]ПИРИДИНОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ | |
| CY1107978T1 (el) | Νeα παρaγωγα πυριδαζiν -3 (2h) - oνης | |
| NO20072379L (no) | Polyeterfunksjonelle siloksaner, sammensetninger med polyetersiloksan, fremgangsmater for fremstilling derav og bruken derav derav | |
| CY1109385T1 (el) | Αναστολεις γυρασης και χρησεις αυτων | |
| CY1106858T1 (el) | Νεα παραγωγα κυκλικου αμιδιου | |
| CY1108254T1 (el) | Ενωσεις που επηρεαζουν τη γλυκοκιναση | |
| ATE366308T1 (de) | Immunostimulierende oligodeoxyribonuklein moleküle | |
| CO5170498A1 (es) | Biaril sulfonamidas son utiles como inhibidores de proliferacion celular | |
| RU2010106198A (ru) | Органополисилоксан | |
| EP1826196A3 (en) | Vinyl ether compounds | |
| EA200800822A1 (ru) | Конъюгаты гидроксиалкилкрахмала и действующего вещества, полученные химическим лигированием через тиазолидин | |
| DK1383903T3 (da) | Fremgangsmåder til fremstilling af askorbinsyre-intermediater i vært-celler | |
| BRPI0410221B1 (pt) | mistura de siloxanos organofuncionais, seu processo de preparação e seu uso | |
| CY1108149T1 (el) | Αβερμεκτινες και μονοσακχαριτες αβερμεκτινων υποκατασταθεντες στη θεση 4΄ και 4΄΄ εχοντες παρασιτοκτονο δραση | |
| ATE403645T1 (de) | Benzamidinderivate mit entzündungshemmender und immunsuppressiver wirkung | |
| ATE517949T1 (de) | Farbstoff und seine anwendung in aufzeichnungsmaterial | |
| CY1105786T1 (el) | Εκδοχα φλαβονων η διαδικασια παρασκευης τους, η εφαρμογη τους ως φαρμακα |